Company Overview

Bio-Gene is an Australian company developing novel bio-insecticides. The Company’s new compounds are active against pest insects and provide significant opportunities for companies developing new insect management products to meet the increasing global market demand for safe and effective pesticides derived from nature.

The target markets for Bio-Gene’s new active compounds are substantial and include: (1) agriculture – to reduce crop yield loss and protect against spoilage in stored grain caused by insect infestations, (2) public health – via control of mosquitoes and protecting the public from mosquito-borne diseases such as malaria and dengue fever, and (3) in consumer home and garden products – to protect against insect infestation.

The unmet needs Bio-Gene is addressing

Bio-Gene is developing two naturally derived insect management products called Qcide® and Flavocide®.

Insects have evolved to become resistant to most of the insecticides currently being used worldwide. Bio-gene’s products in development use a novel method to kill insects (mode of action) and are effective against insects resistant to current commercial products.

Consumers are increasingly demanding safer and greener solutions for insect control. Regulatory authorities around the world are supporting the development of naturally derived solutions via new legislation. Companies are now driven to develop new insect management products meeting the demands of end users, providing environmentally safe and effective insect control. Flavocide and Qcide fit the needs of consumers, regulators and suppliers, being naturally derived and offering a favourable safety profile.

Flavocide and Qcide have also demonstrated synergy with many of the currently approved insect management products. This means that they may be used in combination with these products to provide effective control at lower dose rates. This can lead to reduced impact on non-target pests and the environment and to the control of resistant strains of insect pests.

Bio-Gene’s business model

Bio-Gene’s business model involves licensing insect control companies to use Flavocide and/or Qcide in their new insecticidal products in each of Bio[1]Gene’s target markets. In return, Bio-Gene will receive upfront and milestone payments during the development phase and then royalties based on revenue generated from the sale of these commercial products. Bio-Gene is also able to manage the contract manufacture of Flavocide and production of Qcide and generate a return from the supply of these active ingredients to commercial partners.

Flavocide® and Qcide® are trademarks of Bio-Gene Technology Limited.